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Abstract
Human rhinovirus (HRV) C was recently identified as the third species of HRV using a molecular technique. Infections caused
by previously identified HRVs (A and B) are thought to be limited to the respiratory tract; however, pathogenesis of HRVC is
still largely unknown. A total of 816 nasopharyngeal swabs from hospitalized children with severe respiratory infections in
the Philippines (May 2008–May 2009) were tested for HRV by reverse transcription polymerase chain reaction (RT-PCR), and
243 samples (29.8%) were positive for HRV. Among these patients, serum samples were also tested to determine whether
specific HRV species were associated with viremia. Only 30 serum samples (12.3%) were positive for HRV. However, the HRV
positive rates were different among HRV species, 3% (4/135) for HRVA, 0% (0/25) for HRVB, and 31% (26/83) for HRVC, and
were the highest on 2 days after the onset of symptoms. These results suggest that HRVC may have a different
pathogenicity and can more commonly cause viremia than HRVA and HRVB. Serum positive rates for HRV are affected by
age, i.e., higher positive rates for those aged 1 year or more. HRVC that were detected from serum exhibited the same level
of sequence diversity as those positive only for nasopharyngeal samples in phylogenetic analysis. However, all HRVA which
were detected from serum were clustered in a monophyletic clade based on their 59 non-coding region (NCR) sequences,
which is closely related with a certain HRVC genotype (A2) in 59-NCR. This finding suggests that the 59NCR region may be
associated with viremia.
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Introduction
Human rhinoviruses (HRVs), members of the genus Enterovirus
and the family Picornaviridae [1], possess single-stranded, positive-
sense RNA. The gene structure includes a 59 non-coding region
(59NCR), which is followed by 4 structural proteins (VP1-4) and 7
non-structural proteins (2A–D, 3A–C). More than 100 serotypes
have been identified for HRVs. Based on phylogenetic analysis,
HRV were initially classified into 2 species, HRVA and HRVB.
More recently, molecular techniques have identified previously
unknown HRVs that are genetically distinct from HRVA and
HRVB [2,3,4]. Complete genome sequencing revealed that the
novel HRV shares enough similarities to known HRVs, such as
genome organization and G-C content, to be classified as an HRV
[4]. However, the P1 and 2C+3CD amino acid identity to HRVA
and HRVB is less than 70%, which met the criteria for assignment
as a novel, third species of HRV, HRVC [3,4].
HRVs are the primary causative agents of common cold [5] and
have been considered as clinically less significant because most
HRV infections were thought to be mild. However, recent studies
suggest that HRVs could have significant clinical impacts, such as
hospitalization of children under 5 years of age [6] and
exacerbations of asthma [7,8,9]. The first detection of HRVC
was reported in patients with influenza-like illness in New York
[2]. Many reports from different parts of the world followed the
first report. These reports indicated that HRVC could be
associated with more severe clinical illnesses, including lower
respiratory infections and asthmatic exacerbations, when com-
pared with HRVA and HRVB [4,6,10–13]. However, HRVC has
also been detected in healthy individuals without any acute
respiratory symptoms [14] and therefore clinical significance of
HRVC remains controversial. To date, HRVC detection has only
been performed by molecular methods. Attempts to isolate HRVC
using certain cell lines, which are often used for HRVA and
HRVB isolation, have not been successful [4]. Lack of isolation
methods for HRVC has made it impossible to analyze the
characteristics of the virus including pathogenicity and the
identification of virus receptor [15].
HRV infections were generally thought to be limited to the
upper respiratory tract; however, viremia caused by HRV was
reported in fatal pediatric patients with respiratory illness [16,17].
With the development of molecular techniques, HRV RNA was
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children with asthma exacerbation [18]. However, the occurrence
of viremia has not been compared among the different HRV
species. There is also limited information on pathogenesis of
HRVC. Recently, HRVC was detected in different body sites of a
14-month-old child hospitalized with pneumonia and pericarditis
using real-time PCR [19]. Specimens positive for HRVC included
bronchoalveolar lavage, stool, pericardial effusion, and plasma.
These findings suggest that viremia and systemic infection of
HRVC could occur in patients with severe illness. The current
study was carried out to evaluate if viremia caused by HRV was
present in hospitalized children with severe respiratory infections
in the Philippines and if any specific species of HRV was
associated with viremia.
Results
Out of 816 nasopharyngeal swabs, a total of 272 were positive
for 59NCR by PCR analysis and 243 (29.8%) of them were
positive for HRVs by sequence analysis (135 HRVA, 25 HRVB,
and 83 HRVC; Table 1, Fig. 1). The rest of the PCR positive
samples were low purity to carry out direct sequence (3 samples) or
the other genus Enterovirus (26 cases) including 21 samples of
human enterovirus 68 as previously reported [20]. However, only
137 of the 243 HRV positives samples were positive for VP4-VP2
by PCR analysis (Fig. 2). Serum samples were collected on
admission (S-1) and on day 3 after admission (S-2) if the patient
was still hospitalized. A total of 35 S-1 samples among 243 HRV
positive samples were positive for 59NCR by PCR analysis.
Sequence data for nasopharyngeal and serum samples were
compared. In 30 S-1 positive samples, the sequences of serum
samples had high enough homology (homology ranging from
95%–100%) with the sequences of nasopharyngeal samples to
consider that HRVs in the serum were the same as those in
nasopharyngeal samples [21]. The serum samples for the
remaining 5 samples were positive for other viruses of the
Enterovirus genus: Human enterovirus species A, 1 case; B, 2 cases;
C, 1 case; D, 1 case; based on sequences of their 59NCR. The
overall HRV positive rate in S-1 samples was 12.3% (30/243).
However, positive rates were significantly different among species,
4 out of 135 (3.0%) with HRVA, 0 out of 25 (0%) with HRVB,
and 26 out of 83 (31.3%) with HRVC (Table 1). The odds ratio of
HRVC positive in sera (15.04) against the rest of HRVs was
statistically significant (p,0.01). Of 28 S-2 samples, 2 were positive
for HRVC (Table 1).
For HRVA the median duration of serum positive and negative
cases were 2.5 days (95% CI 1.23–4.27) and 4 days (95% CI 4.57–
6.25) (p=0.18). The positive rate was highest (7.7%) among the
samples collected on day 2 (Fig. 3). For HRVC, the median
duration of serum positive and negative cases were 2 days (95%CI
1.93–3.91) and 3 days (95% CI 3.36–4.85) (p,0.05) respectively.
The serum positive rate also reached its highest mark (60%) on day
2 and then decreased gradually after day 2. S-2 positive was
detected up to day 6 (Fig. 3). There was only1 positive sample
collected after day 8 (day 14). HRV positivity in S-1 samples by
age group is shown in Table 2. There was no positive patient
among children younger than 6 months and positivity increased
toward 12–23 months for both HRVA and HRVC (Table 2). For
HRVC, serum positive rates for patients younger than 6 months
were significantly lower than that for other age groups (p,0.01),
and age group 12–23 month showed significantly higher serum
positive rate (p,0.05). Age groups of 24–35 months and 36
months or more also had high serum positive rates (50.0% and
44.4%, respectively), but no statistical differences were observed
when compared with other age groups.
Clinical symptoms and respiratory functions between the serum
positive and negative patients were compared. Because there were
no HRV-serum positive patients among the patients aged under 6
months, analysis was performed only for the age groups over 6
months. On an average, HRVA-serum positive patients exhibited
significantly lower SpO2 values than the serum negative patients
(median: 86 vs. 93.5, p,0.01; Fig. 4a). HRVC-serum positive
patients also had lower SpO2 values in all age groups but statistical
significance was observed only for 6–11 months age group
(median: 92 vs. 96, p,0.05) (Fig. 4b). Wheezing was observed
more commonly in HRVA-serum positive patients (4/4: 100%)
than in HRVA-serum negative patients (37/82: 45.1%) (p,0.05).
Wheezing was also more common in HRVC-serum positive
patients (18/26: 69.2%) than in the serum negative patients (16/
33: 48.5%), but there was no statistical significance (p=0.11).
Finally, case fatality rates (CFRs) between the serum positive and
serum negative patients were also compared. CFRs were lower for
HRVA- and HRVC-serum positive patients than for the serum
negative patients. HRVA serum positivity (0/4: 0%) vs. HRVA
serum negativity (7/82: 8.5%) (p=1.0) and HRVC serum
positivity (1/26: 3.8%) vs. HRVC serum negativity (4/33:
12.1%)(p=0.37). There were no statistical differences for neither
HRVA nor HRVC.
Phylogenetic trees were constructed for 59NCR (Fig. 1) and
VP4-VP2 (Fig. 2). All 3 species, HRVA, HRVB, and HRVC,
Table 1. HRV RNA positivity in sera among patients positive for HRV in nasopharyngeal samples.
Nasopharyngeal First serum sample (S-1) Second serum sample (S-2)
swabs (n=816)
No positive (%) No tested No positive (%) OR (95%CI) No tested No positive (%)
HRVA 135 (16.5%) 135 4 (3%)* 0.12(0.04–0.34) 4 0
HRVB 25 (3.1%) 25 0** - Not tested Not tested
HRVC 83 (10.2%) 83 26 (31.3%)* 15.04 (5.42–41.73) 24 2 (8.3%)
Total HRVs 243 243 30 (12.3%) 28 2 (7.1%)
First serum samples were collected on the day of admission (S-1). Second serum samples were collected 3 days after admission (S-2). OR is the odds ratio calculated with
each species and the rest of the groups as the point of reference.
*p,0.01,
**p=0.05.
doi:10.1371/journal.pone.0027247.t001
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HRVC-serum positive samples were scattered in many different
clades of 59NCR and VP4-VP2 (Fig. 1 and 2). The mean p-
distance on 59NCR for all HRVC and HRVC-serum positives
were 0.257 and 0.261, respectively. Although there were only 4
HRVA-serum positive samples, all of them were closely related on
59NCR tree (Fig. 1). The mean p-distances on 59NCR for all
HRVA and HRVA serum positives were 0.185 and 0.108,
respectively. All 4 HRVA-serum positives were under a specific
branch (Fig. 1) that is shared by one group of HRVC. This HRVC
group was previously named A2 by Kiang et al. [22]. While the
mean p-distance on 59NCR between the A2 group (HRVC) and
HRVA-serum positive samples was 0.189, it was 0.224 between all
HRVA and HRVA-serum positive samples. Only 2 out of 4
HRVA-serum positive samples were positive for VP4-VP2 and
sequenced. They belonged to 2 clades, which shared 2 previously
known serotypes, HRV12 and HRV53 (Fig. 2).
Discussion
This study has exhibited high detection rate of HRVC RNA in
the serum samples from hospitalized children with severe acute
respiratory infections. The HRVC-serum positivity rate was
significantly higher than that of combined data for HRVA and
HRVB (Table 1), which suggests that HRVC may cause viremia
more commonly than HRVA and HRVB. Xatzipsalti et al.
reported that viremia caused by rhinovirus in children with
respiratory infections was high (10/88, 11.4%) [18]; however, they
utilized semi-nested PCR, which is more prone to false positive
results, and moreover, the results obtained were not species
specific. To the best of our knowledge, ours is the first study to
assess the occurrence of viremia caused by HRV in a large case
series by first-round PCR only and determine the species of HRV
by sequencing analysis. A previous case report of pneumonia and
pericarditis identified HRVC at many body sites, including
plasma, by real-time PCR [19]. Our present study detected as
many as 26 HRVC-serum positive cases. However, both studies
detected HRVC in blood samples of severely ill children. Further
studies should be conducted to clarify if viremia caused by HRVC
is commonly seen in milder cases of HRVC infection.
HRVC was detected in serum samples collected between day 1
and day 14. HRVC-serum positive cases showed significantly
earlier duration from the onset compared with HRVC-serum
negative cases. Clearance of viral RNA from serum generally
occurred by day 7 after the onset of symptoms in most of the
patients (Fig. 3). Although many studies have reported that HRVC
may be associated with more severe clinical symptoms than
HRVA and HRVB infections [4,6,10–13], detection of HRVC in
healthy subjects has also been reported [14]. HRVC pathogenesis,
especially its association with severe illness, is still to be
determined. The fact that HRVC RNA was detected in serum
only during the acute phase in severely ill patients may support the
hypothesis that HRVC is associated with clinical disease. A
prevailing belief was that the major site of infection of HRVs is
limited to the respiratory tract [23]. However, this study result led
to the hypothesis that HRVC has different pathogenesis than
HRVA and HRVB, which may not be restricted to the respiratory
tract and may cause systemic infections similar to other members
of the genus Enterovirus [24]. Sequences and predicted capsid
structure of HRVC are also significantly different from those of
known and cultivable HRVA and HRVB [4,15]. A study group
attempted to adapt high-titer HRVC, generated using a reverse
Figure 1. Phylogenetic tree of 59NCR. Black open circle indicates
the HRVs detected only from nasopharyngeal swab samples. Filled red
circle and triangle indicate S-1 and S-2 serum positives, respectively.
Blue: HRVA, Yellow: HRVB, and Red: HRVC. Red branch indicates specific
clade that is shared between HRVA and HRVC (A2). Phylogeny was
inferred using NJ method on MEGA 4.1.
doi:10.1371/journal.pone.0027247.g001
Figure 2. Phylogenetic tree of VP4-VP2. Black open circle indicates
the HRVs detected only from nasopharyngeal swab samples. Red circle
indicates the HRVs detected from both nasopharyngeal swab and
serum samples. Phylogeny was inferred using NJ method on MEGA 4.1.
doi:10.1371/journal.pone.0027247.g002
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failed attempt suggested the existence of an HRVC-specific
receptor that mediates interactions with microbial products found
in vivo and/or other types of cells [25]. Collectively, the unique
characteristics of HRVC suggest that pathogenesis of HRVC may
be different from that of HRVA or HRVB.
Sequence diversity of HRVC-serum positive samples was
similar to that in samples positive for HRVC in only nasopha-
ryngeal samples. Analysis of both 59NCR and VP4-VP2 sequences
exhibited that there were no specific HRVC genotypes associated
with serum positivity (Fig. 1 and 2). The mean p-distance in the
case of HRVC-serum positive samples and all HRVC samples also
did not show any differences based on 59NCR sequence. In
contrast, although HRVA detected in the nasopharynx were as
diverse as HRVC, we found that HRVA-serum positive samples
were limited to only a particular clade that shares higher similarity
with a specific type of HRVC (A2 clade) [22] in the 59NCR region
(p-distance: 0.189 vs. 0.224) (Fig. 1). Many studies have shown that
some HRVC variants have HRVA-like 59NCRs (Ca) while others
have HRVC-like 59NCRs (Cc) [26–28]. The A2 clade is a Ca type
of HRVC, i.e., HRVC with an HRVA-like 59NCR, which may
have been created by recombination between HRVA and HRVC.
There are multiple recombination breakpoints in the 59NCR for
Ca [26–28] indicating the existence of several recombination
events. Although there have been many reports of HRVC with
HRVA-like 59NCRs, no HRVA with HRVC 59NCR have been
reported [28]. Our data also confirmed that all HRVA have
HRVA-like 59NCR and VP4-VP2. At this moment, it is unclear
whether having HRVA-like 59NCR is beneficial for virus
replication. However, it is possible that possessing a specific type
of 59NCR that is closely related to the A2 clade of HRVC may be
correlated with viremia caused by HRVA. Some experimental
recombinants of Coxsackieviruses, constructed by exchanging
59NCRs, exhibited changing tissue tropism [29–32]; however, it is
also possible that such clustering of serum-positive HRVA
occurred by chance since the number of serum positive HRVA
was small. Further studies should be conducted to determine if
there is any relationship between the structure of 59NCR and
tissue tropism of HRVA and HRVC.
Although more than half of our study subjects were younger
than1 year, HRVC-serum positivity rates were higher in subjects
aged 1 year or more (Table 2). No HRVA or HRVC RNA was
detected in serum samples from children younger than 6 months
old. And higher serum positive rates were observed for those aged
1 year or more. Polioviruses, another species of the genus
Enterovirus, exhibited lower rates of viremia after oral polio
vaccination in subjects less than 6 months old because of the
existence of maternal antibody [33]. Furthermore, the duration of
viremia in Coxsackievirus B3 antibody-treated animals was
shortened because of early virus clearance from the blood and
heart [34]. Thus, it is possible that maternal antibodies against
HRVs present in children less than 6 months may suppress or
possibly prevent the occurrence of viremia.
A previous study showed an association between asthma
exacerbation and viremia caused by HRV [18]. In the present
study, HRVA patients of all age groups showed a significant
Table 2. HRV RNA positivity in sera by age group.
Total HRVA HRVC
nasopharyngeal swabs serum+ serum2 % OR (95%CI) P value serum+ serum2 % OR (95%CI) P value
Age ,6 288 0 47 0.0 - 0.30 0 24 0.0 - ,0.01
(months) 6–11 177 1 26 3.7 1.07 (0.60–1.90) 1.00 3 9 25.0 0.95 (0.80–1.14) 0.75
12–23 170 2 29 6.5 1.56 (0.58–4.17) 0.23 11 11 50.0 1.40 (0.98–1.99) 0.03
24–35 79 0 11 0.0 - 1.00 8 8 50.0 1.24 (0.94–1.64) 0.07
36– 101 1 16 5.9 1.17 (0.66–2.07) 0.42 4 5 44.4 1.08 (0.90–1.30) 0.45
Total 816 4 131 3.0 26 57 31.3
OR is odds ratio calculated with each age groups and the rest of the groups within specie as the point of reference.
doi:10.1371/journal.pone.0027247.t002
Figure 3. HRV RNA detection in serum by RT-PCR based on number of days after onset. S-1 and S-2 indicate serum samples that were
collected upon admission (S-1) and 3 days after admission (S-2). Date shown is the sampling date measured from onset of symptoms. Only PCR
samples positive on S-1 were proceeded for the next analysis on S-2. The positivity rate was calculated with total (S-1+S-2) positive and negative
numbers.
doi:10.1371/journal.pone.0027247.g003
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(Fig. 4a). However, in our study only one age group of 6–11
months showed statistical difference for HRVC (Fig. 4b). This may
be due to some outliers for serum negative cases and relatively
small number of cases in each category (Table 2). In addition,
HRVA-serum positive patients showed significant higher frequen-
cy of wheezing, although there were only four HRVA serum
positive cases.
HRVC-serum positive patients exhibited a higher frequency of
wheezing in all age groups except the 12–23 months age group,
although the levels of these differences were not statistically
significant. The causative link between RNA serum positivity and
observed clinical features, if any, remains unclear. Many reports
have indicated that HRVC infections may result in more severe
respiratory symptoms than HRVA and HRVB infections [4,6,10–
13]. Severe symptoms of HRVC may be caused by systemic
Figure 4. SpO2 by age groups with and without HRV RNA in serum. S+ and S2 indicate RNA serum positivity and serum negativity,
respectively. Bar indicates the range between maximum and minimum values. Thick bar indicates interquartile range. Median and outliers are shown
as a lateral bar and asterisk, respectively.
{p,0.05,
{{ p,0.01.
doi:10.1371/journal.pone.0027247.g004
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to be associated with severe fatal cases [16,17]; however, any
association between serum positivity and fatal outcomes was not
observed in our analysis.
Finally, the possibility of viral RNA leakage into serum cannot
be ruled out. Because there is no established method to isolate
HRVC, it is not possible to prove that there are infectious viruses
in the blood. However, significant association between HRV RNA
serum positivity and the duration of the detection of serum
positivity after onset of symptoms still supports the hypothesis that
HRVC and certain types of HRVA could cause viremia in the
acute phase of infections.
In conclusion, detection rates of HRVC in serum were higher
than that of HRVA and HRVB in this study. It has been reported
that HRVC infections are associated with more severe clinical
symptoms. If viremia caused by HRVC is more common, such
viremia may result in systemic infection and more severe clinical
symptoms. Because HRV infections were thought to be limited to
the respiratory tract, the occurrence of viremia caused by HRVC
had not been examined. Although still not well understood, our
findings suggest that the pathogenesis of HRVC may be
significantly different from that of HRVA and HRVB.
Materials and Methods
Ethics Statement
The study protocol was approved by the Institutional Review
Board of Tohoku University Graduate School of Medicine,
RITM, and EVRMC. The parents or guardians gave written
informed consent for their children to participate in the study.
Samples were collected at the Eastern Visayas Regional Medical
Center, Tacloban, Philippines, from pediatric patients who were
diagnosed with severe pneumonia according to the case definition
of the Integrated Management of Childhood Illness (IMCI) [35],
‘‘a child with cough or difficulty in breathing and with any of the
following signs—unable to drink or breastfeed, lethargic or
unconscious, vomiting, convulsions, or chest indrawing or stridor
in a calm child—is classified as having severe pneumonia or very
severe disease.’’ A total of 816 children (54% male, 46% female;
aged 7 days –14 years; median age, 9 months) were enrolled in
May 2008–May 2009. Nasopharyngeal swabs and serum samples
were obtained on the day of admission (S-1). Serum samples were
also collected on 3 days after admission (S-2) if the patient was still
hospitalized.
RNA was extracted from the nasopharyngeal swabs using
QIAamp MinElute Virus Spin kit (Qiagen, Hilden, Germany).
Reverse transcription was performed by SS III Reverse Tran-
scriptase with random hexamer (Invitrogen Carlsbad, CA, USA).
Screening for the presence of HRV was performed by single-
round (40 cycles) PCR targeting the 59NCR [22] with ExTaq
(TaKaRa Bio, Otsu, Japan). Negative and positive controls were
included in each run. The PCR products were purified by
TaKaRa SUPREC-PCR Kit (TaKaRa Bio, Otsu, Japan),
sequenced using BigDye Terminator version 1.1 or 3.1 (Applied
Biosystems, Foster City, CA, USA), and analyzed using Applied
Biosystems 3130 or 3700 Genetic Analyzer (Applied Biosystems,
Foster City, CA, USA). HRV species (A, B, and C) were
determined by phylogenetic analysis using MEGA (version 4)
including reference strains [22,36]. The mean p-distance was
calculated using MEGA (version 4). For 59NCR positive samples,
further analysis was carried out to amplify the VP4/VP2 region
[37] using Taq (TaKaRa Bio, Otsu, Japan) to confirm the 59NCR
result. S-1 samples for which corresponding nasopharyngeal swabs
were positive for HRV were subject to HRV detection by the same
method as above except using Purelink (Invitrogen Carlsbad, CA,
USA) for RNA extraction. For S-1 positive samples, S-2 samples
were also tested to detect HRV by RT-PCR utilizing the same
procedure as above. Nasopharyngeal and serum samples were
handled separately at every procedure to prevent cross-contam-
ination. All HRV sequences from serum positive samples will be
deposited into GenBank. The Mann-Whitney U test and x square
test were used for the comparison of continuous and categorical
data, respectively. For duration length analysis, S-1 and S-2–
positive cases were pooled together as a single set. Odds ratio (OR)
and 95% CI were calculated by comparison of PCR positivity for
the whole study and also between age groups. All statistical
analyses were carried out using SPSS 18 (SPSS, Inc., Chicago, IL,
USA).
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